title: Cardiac calcium handling on trial: targeting the failing cardiomyocyte signalosome.
authors.affiliation: From the Molecular and Translational Cardiology, Department of Internal Medicine III (S.T.P., P.R., H.A.K., P.M.), DZHK (German Center for Cardiovascular Research), Partner site Heidelberg/Mannheim (H.A.K., P.M.), Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; and Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, PA (P.M.).
authors.forename: Sven T
authors.initials: ST
authors.lastname: Pleger
authors.forename: Philip
authors.initials: P
authors.lastname: Raake
authors.forename: Hugo A
authors.initials: HA
authors.lastname: Katus
authors.forename: Patrick
authors.initials: P
authors.lastname: Most
mesh_terms: D005260:Female; D015316:Genetic Therapy; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D008297:Male; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases / Q000235:genetics*
chemical_list: D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; C506946:ATP2A2 protein, human
keywords: Editorials; calcium signaling; genetic therapy; heart failure